Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
基本信息
- 批准号:6630241
- 负责人:
- 金额:$ 14.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-15 至 2007-12-31
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis Shigella actins bacteria infection mechanism bacterial cytopathogenic effect bacterial proteins biological signal transduction cytoskeleton genetically modified animals guanine nucleotide binding protein guanosinetriphosphatases host organism interaction intestinal mucosa laboratory mouse membrane proteins pathologic process protein structure function site directed mutagenesis
项目摘要
DESCRIPTION (provided by applicant): Shigella are gram negative enteric pathogens that cause severe diarrheal disease and have been classified as a Category B Biological Agent. Shigella pathogenesis requires bacterial invasion of the colonic epithelium and bacterial spread through the colonic mucosa. Shigella entry into epithelial cells is mediated by effector molecules, secreted through a type III secretion apparatus, that activate Rho family GTPase signaling pathways to induce the formation of cell surface projections and membrane ruffles that engulf the bacteria by macropinocytosis. Both Cdc42 and Rac have been implicated as having a role in the Shigella entry process. Cdc42 is known to activate Rac; it is not clear whether Cdc42 involvement in Shigella entry is mediated exclusively via this link. Moreover, the downstream effectors of Cdc42 and/or Rac activation during Shigella entry are unknown. We have recently confirmed that the major Shigella pathway is Cdc42-dependent. However, we have also demonstrated the existence of a novel Cdc42-independent invasion pathway. Furthermore we have shown that the only known downstream effector of Cdc42 that activates the actin cytoskeleton, N-WASP, is not involved in Shigella entry. Once in the cytoplasm, Shigella moves by active assembly of an actin tail. Actin tail formation is mediated by the Shigella outer membrane protein IcsA, which binds and activates N-WASP. Activated N-WASP stimulates Arp2/3 complex-mediated actin assembly. The molecular mechanism by which IcsA binds and activates N-WASP is poorly understood.
Our goals in this proposal are to:
1. Define the specific roles of Cdc42 and Rac in Shigella entry;
2. Identify and characterize the downstream effectors of Rho family activation during Shigella entry; and,
3. Elucidate the mechanism(s) by which Shigella IcsA activates N-WASP and determine whether this mechanism mimics Cdc42 activation of N-WASP
These studies will define the specific cellular signaling pathways required for Shigella entry and actin tail formation and will identify downstream pathways of Rho family activation.
描述(由申请方提供):志贺氏菌属是革兰氏阴性肠道病原体,可引起严重腹泻病,被归类为B类生物制剂。志贺氏菌的发病机制需要细菌侵入结肠上皮和细菌通过结肠粘膜传播。志贺氏菌进入上皮细胞是由效应分子介导的,通过III型分泌装置分泌,其激活Rho家族GT3信号传导途径以诱导细胞表面突起和膜皱褶的形成,所述突起和膜皱褶通过巨胞饮吞噬细菌。Cdc 42和Rac都被认为在志贺氏菌进入过程中发挥作用。已知Cdc 42激活Rac;尚不清楚Cdc 42参与志贺氏菌进入是否仅通过此链接介导。此外,Cdc 42和/或Rac激活的下游效应在志贺氏菌进入是未知的。我们最近证实志贺氏菌的主要途径是Cdc 42依赖性的。然而,我们也证明了一个新的Cdc 42独立的入侵途径的存在。此外,我们已经表明,唯一已知的下游效应Cdc 42,激活肌动蛋白细胞骨架,N-WASP,不参与志贺氏菌进入。一旦进入细胞质,志贺氏菌通过肌动蛋白尾的主动组装而移动。肌动蛋白尾的形成是由志贺氏菌外膜蛋白IcsA介导的,其结合并激活N-WASP。活化的N-WASP刺激Arp 2/3复合物介导的肌动蛋白组装。IcsA结合和激活N-WASP的分子机制知之甚少。
我们在本提案中的目标是:
1.明确Cdc 42和Rac在志贺菌进入中的具体作用;
2.鉴定和表征志贺氏菌进入期间Rho家族激活的下游效应物;以及,
3.阐明志贺氏菌IcsA激活N-WASP的机制,并确定该机制是否模拟Cdc 42激活N-WASP
这些研究将确定志贺氏菌进入和肌动蛋白尾形成所需的特定细胞信号通路,并将确定Rho家族激活的下游通路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott B Snapper其他文献
Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
抗肿瘤坏死因子α在极早发炎症性肠病中的功效和安全性。
- DOI:
10.1093/ibd/izad196 - 发表时间:
2023 - 期刊:
- 影响因子:4.9
- 作者:
L. Collen;V. Mitsialis;David Y. Kim;Mairead Bresnahan;Jessica Yang;M. Tuthill;A. Combs;J. Barends;M. Field;Enju Liu;R. Bearup;I. Okoroafor;Christoph Klein;A. Muise;A. Bousvaros;J. Ouahed;Scott B Snapper - 通讯作者:
Scott B Snapper
Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort
罕见疾病队列中深度学习模型与临床级变异致病性分类之间的不一致
- DOI:
10.1101/2024.05.22.24307756 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
S. Kong;In;Lauren V Collen;Arjun K Manrai;Scott B Snapper;Kenneth D Mandl - 通讯作者:
Kenneth D Mandl
Scott B Snapper的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott B Snapper', 18)}}的其他基金
Employing novel humanized murine strains to develop hematopoietic stem cell gene therapeutic approaches for very early-onset inflammatory bowel disease due to IL10-receptor deficiency.
采用新型人源化小鼠品系开发造血干细胞基因治疗方法,用于治疗因 IL10 受体缺陷所致的极早发炎症性肠病。
- 批准号:
9535567 - 财政年份:2017
- 资助金额:
$ 14.81万 - 项目类别:
Type III interferon Control of Mucosal Immunity
III 型干扰素控制粘膜免疫
- 批准号:
10587625 - 财政年份:2017
- 资助金额:
$ 14.81万 - 项目类别:
Exploring Regulatory T Cell Dysfunction in a Murine Model of Colitis
探索小鼠结肠炎模型中的调节性 T 细胞功能障碍
- 批准号:
8232674 - 财政年份:2011
- 资助金额:
$ 14.81万 - 项目类别:
Deciphering the Role of WASP Family Proteins in T Cell Function
解读 WASP 家族蛋白在 T 细胞功能中的作用
- 批准号:
8147996 - 财政年份:2010
- 资助金额:
$ 14.81万 - 项目类别:
Exploring Regulatory T Cell Dysfunction in a Murine Model of Colitis
探索小鼠结肠炎模型中的调节性 T 细胞功能障碍
- 批准号:
7877475 - 财政年份:2009
- 资助金额:
$ 14.81万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
6800508 - 财政年份:2003
- 资助金额:
$ 14.81万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
6833455 - 财政年份:2003
- 资助金额:
$ 14.81万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
7161772 - 财政年份:2003
- 资助金额:
$ 14.81万 - 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
- 批准号:
7012813 - 财政年份:2003
- 资助金额:
$ 14.81万 - 项目类别:
The Pathogenesis Of Colitis In A Novel Th2 Model Of IBD
新型 IBD Th2 模型中结肠炎的发病机制
- 批准号:
6418028 - 财政年份:2002
- 资助金额:
$ 14.81万 - 项目类别:
相似国自然基金
Shigella sp. PIB菌产生长链脂肪酸诱发顽固性功能性便秘的机制研究
- 批准号:32371176
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
IBD原籍菌Shigella通过Neu5Ac碳源竞争拮抗外源Faecalibacterium定植导致FMT后肠黏膜修复抑制的机制研究
- 批准号:82300753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Shigella sp. PIB细菌感染导致顽固性功能性便秘的机制研究
- 批准号:n/a
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
顽固性功能性便秘致病菌Shigella sp PIB溯源和分子流行病学研究
- 批准号:82250003
- 批准年份:2022
- 资助金额:300.00 万元
- 项目类别:专项项目 国家自然科学基金外国青年学者研究基金
相似海外基金
The epidemiology of transmissible antimicrobial resistance among Shigella species
志贺菌属中传播性抗菌药物耐药性的流行病学
- 批准号:
MR/X000648/1 - 财政年份:2024
- 资助金额:
$ 14.81万 - 项目类别:
Research Grant
Understanding the increasing prevalence of Shigella sonnei
了解宋内志贺氏菌日益流行的情况
- 批准号:
MR/X00080X/1 - 财政年份:2023
- 资助金额:
$ 14.81万 - 项目类别:
Research Grant
Pyroptotic Macrophages Traps Against Shigella Infection
焦亡巨噬细胞捕获志贺氏菌感染
- 批准号:
10646015 - 财政年份:2023
- 资助金额:
$ 14.81万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 14.81万 - 项目类别:
Shigella mediated regulation of epithelial cell inflammasomes
志贺氏菌介导的上皮细胞炎症小体的调节
- 批准号:
10608342 - 财政年份:2023
- 资助金额:
$ 14.81万 - 项目类别:
Shigella Conjugate Vaccine (SCV4) Development, Characterization, and Pre-clinical Evaluation
志贺氏菌结合疫苗 (SCV4) 的开发、表征和临床前评估
- 批准号:
10704325 - 财政年份:2023
- 资助金额:
$ 14.81万 - 项目类别:
A cross protective multivalent vaccine for Shigella and ETEC
针对志贺氏菌和 ETEC 的交叉保护性多价疫苗
- 批准号:
10633470 - 财政年份:2023
- 资助金额:
$ 14.81万 - 项目类别:
Role of two-component signaling system loss in behaviour of Shigella flexneri
双组分信号系统损失在福氏志贺氏菌行为中的作用
- 批准号:
574561-2022 - 财政年份:2022
- 资助金额:
$ 14.81万 - 项目类别:
University Undergraduate Student Research Awards
Characterization of assembly and activation of the Shigella type III secretion injectisome
III 型志贺氏菌分泌注射剂的组装和激活的表征
- 批准号:
10535257 - 财政年份:2022
- 资助金额:
$ 14.81万 - 项目类别:
Characterization of assembly and activation of the Shigella type III secretion injectisome
III 型志贺氏菌分泌注射剂的组装和激活的表征
- 批准号:
10673048 - 财政年份:2022
- 资助金额:
$ 14.81万 - 项目类别: